HIM
GSK icon

Hillsdale Investment Management’s GSK GSK Stock Holding History

Hillsdale Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-224
Closed -$10K – 599
2020
Q4 		$10K Buy
224
+24
+12% +$1.1K ﹤0.01% 495
2020
Q3 		$9K Buy
200
+96
+92% +$4.81K ﹤0.01% 497
2020
Q2 		$5K Sell
104
-24
-19% -$1.23K ﹤0.01% 505
2020
Q1 		$6K Hold
128
– – ﹤0.01% 507
2019
Q4 		$8K Hold
128
– – ﹤0.01% 499
2019
Q3 		$7K Buy
128
+40
+45% +$2.06K ﹤0.01% 521
2019
Q2 		$4K Buy
88
+16
+22% +$803 ﹤0.01% 549
2019
Q1 		$4K Buy
72
+16
+29% +$800 ﹤0.01% 543
2018
Q4 		$3K Sell
56
-8
-13% -$394 ﹤0.01% 528
2018
Q3 		$3K Buy
64
+8
+14% +$406 ﹤0.01% 431
2018
Q2 		$3K Sell
56
-8
-13% -$403 ﹤0.01% 447
2018
Q1 		$3K Sell
64
-8
-11% -$373 ﹤0.01% 417
2017
Q4 		$3K Sell
72
-32
-31% -$1.48K ﹤0.01% 429
2017
Q3 		$5K Buy
+104
New +$5.28K ﹤0.01% 393
2015
Q4 		– Sell
-2,560
Closed -$123K – 533
2015
Q3 		$123K Sell
2,560
-80
-3% -$4.16K 0.04% 377
2015
Q2 		$137K Buy
2,640
+640
+32% +$36K 0.04% 378
2015
Q1 		$115K Buy
2,000
+480
+32% +$27.5K 0.03% 386
2014
Q4 		$81K Sell
1,520
-80
-5% -$4.48K 0.02% 419
2014
Q3 		$92K Sell
1,600
-800
-33% -$49K 0.03% 391
2014
Q2 		$160K Sell
2,400
-560
-19% -$37.9K 0.04% 355
2014
Q1 		$198K Sell
2,960
-4,320
-59% -$292K 0.06% 316
2013
Q4 		$486K Buy
7,280
+1,320
+22% +$85.6K 0.14% 105
2013
Q3 		$374K Buy
5,960
+2,600
+77% +$167K 0.11% 134
2013
Q2 		$210K Buy
+3,360
New +$213K 0.07% 285

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Hillsdale Investment Management's GSK Position: Q1 2021 in Review

Hillsdale Investment Management sold out of GSK (GSK) in Q1 2021, closing a stake of 224 shares — an estimated $10K sold.

Hillsdale Investment Management first reported a position in GSK in Q2 2013 and held it in 24 quarters. The position peaked at $486K in Q4 2013. 775 funds tracked by Wall St. Rank hold GSK as of Q1 2021.

  • Hillsdale Investment Management reported no remaining GSK position as of Q1 2021 after selling out during the quarter.
  • Hillsdale Investment Management sold 224 GSK shares in Q1 2021, an estimated $10K.
  • Hillsdale Investment Management first reported a position in GSK in Q2 2013 and held it in 24 quarters.
  • Hillsdale Investment Management's GSK position peaked at $486K in Q4 2013.
  • 775 funds tracked by Wall St. Rank held GSK as of Q1 2021.

Based on Hillsdale Investment Management's 13F filing for Q1 2021, filed 22 Apr 2021.